![Mark Newman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Newman
Directeur Technique/Scientifique/R&D chez
GEOVAX LABS
Fortune : - $ au 31/10/2026
Profil
Mark J.
Newman is the founder of Newmark Diagnostics LLC, founded in 2016.
Dr. Newman is currently Chief Scientific Officer at GeoVax Labs, Inc., a position held since 2020.
Former positions include Vice President-Research & Development at Epimmune, Inc. in 2005, Vice President-Research & Development at Emergent Travel Health, Inc. in 2009, Vice President-Research & Development at Pharmexa A in 2008, Vice President-Infectious Diseases at IDM Pharma, Inc. in 2011, and Vice President-Research & Development at GeoVax Labs, Inc. from 2010 to 2013.
Dr. Newman was also a Member at Louisiana State University.
Education includes undergraduate and graduate degrees from The Ohio State University and a doctorate from John Curtin School of Medical Research.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GEOVAX LABS, INC. -.--% | 28/08/2026 | 0 ( -.--% ) | - $ | 31/10/2026 |
Postes actifs de Mark Newman
| Sociétés | Poste | Début |
|---|---|---|
| GEOVAX LABS | Directeur Technique/Scientifique/R&D | 25/08/2020 |
Anciens postes connus de Mark Newman
| Sociétés | Poste | Fin |
|---|---|---|
| GEOVAX LABS | Directeur Technique/Scientifique/R&D | 01/01/2013 |
IDM Pharma, Inc.
 IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Corporate Officer/Principal | 28/04/2011 |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Directeur Technique/Scientifique/R&D | 01/12/2009 |
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Directeur Technique/Scientifique/R&D | 01/12/2008 |
Epimmune, Inc.
 Epimmune, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to treat and prevent infectious diseases and cancer | Directeur Technique/Scientifique/R&D | 01/12/2005 |
Formation de Mark Newman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Epimmune, Inc.
Epimmune, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to treat and prevent infectious diseases and cancer | Health Technology |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Health Technology |
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Louisiana State University
 Louisiana State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDM Pharma, Inc.
IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Health Technology |
GeoVax Labs, Inc.
 GeoVax Labs, Inc. BiotechnologyHealth Technology Develops vaccines for diseases caused by Human Immunodeficiency Virus and other infectious agents | Health Technology |
Newmark Diagnostics LLC | |
John Curtin School of Medical Research
 John Curtin School of Medical Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
